ARCHIVES

NCA To Hear Centers’ Reaction, Other Subcommittee, Scientific Reports

This article is from The Cancer Letter archive.

Vol. 03 No. 45 | November 11, 1977

Download PDF Visit The Full Archive

Related Articles

In Brief: Weinstein Names Permanent Director Of Columbia Comprehensive Center; Gottsman Heads Institute

February 8, 1985

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

June 20, 1986

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

House subcommittee’s 5.6% Increase For NIH includes $2.5 Billion for NCI

July 18, 1997

Questions Still Surround 88 BCDDP Patients Found With Minimal Cancer; DCCR Asks for Another Review

October 28, 1977